-
Orthofix adds new executive leader
Lucas Vitale joined Orthofix as chief people and business operations officer, the company said March 18. -
Bioretec earns breakthrough designation for spinal interbody cage
Bioretec earned the FDA's breakthrough device designation for its RemeOs spinal interbody cage, the company said March 14. -
5 medtech notes: Stryker, Xtant Medical and more
Here are five key updates from spine and orthopedic devicemakers since March 6. -
Apple Vision Pro used in its 1st UK spinal operation
Surgeons at London-based Cromwell Hospital became the first in the country to use tech company Apple's Vision Pro headset during a spinal operation. -
Washington payer adds coverage for lumbar disc implant
The largest commercial payer in Washington implemented coverage for Centinel Spine's Prodisc L implant, the devicemaker said March 12. -
L&K Spine's revolutionary achievement: 1,200 level implantation of PathLoc-TM, PLIF/TLIF Expandable Cage
L&K Spine Inc. proudly announces a groundbreaking milestone in the field of spine surgery: the 1,200th successful implantation of PathLoc-TM, PLIF/TLIF Expandable Cage in US as of January 2024. This achievement marks a significant advancement in spine surgery and underscores our commitment to improving patient outcomes through innovative products. -
Artificial disc replacement to crack $1B by 2030
The artificial disc replacement market is expected to grow at a compound annual growth rate of 12.3% between 2023 and 2030, according to Vantage Market Research. -
Xtant Medical boosts credit facility with MidCap Financial
Xtant Medical had its credit facility with MidCap Financial raised from $8 million to $17 million, according to a March 7 news release. -
3 spine, orthopedic medtech warnings, recalls in 2024
Becker's reported on three product recalls from spine and orthopedic medtech companies so far in 2024. -
Medtronic launches data collection tool for spine
Medtronic launched the UNiD ePro service in the U.S., the company said March 6. -
OrthoPediatrics' revenue grows 22%
OrthoPediatrics has announced a revenue of $148.7 million in 2023, up 22% from the year prior. -
5 medtech notes: Orthofix, ZimVie and more
Here are five key developments from spine devicemakers since Feb. 28. -
Orthofix sees 64% increase in Q4 revenue
Orthofix's fourth quarter sales grew 64%, and its full year revenue rose 62%, according to financial results posted March 5. -
2 spine companies launching public offering
Two spine companies launched public offerings since Feb. 26. -
Alphatec CFO sells 121K shares of stock
Alphatec CFO John Koning sold 121,601 shares of company stock on March 1, according to SEC documents. -
OrthoPediatrics launches new scoliosis treatment system
OrthoPediatrics has launched a new system, the Response rib and pelvic fixation system, to treat children with early onset scoliosis. -
Medtronic named among world's 'most ethical' companies
Orthopedic and spine tech manufacturer Medtronic has been named among the world's most ethical companies by for-profit ethical standards company the Ethisphere Institute. -
Stryker, Zimmer Biomet, J&J execs among the most 'influential' in healthcare
CEOWorld Magazine released its latest list of "World's Most Influential CEOs and Business Executives," and three orthopedic devicemaker leaders are on it. -
3 spine, orthopedic devices earning FDA nods
Here are three spine and orthopedic devices that have earned FDA clearance that Becker's has reported on since Feb. 22: -
Orthofix realigns spine business, names bone growth therapies leader
Orthofix is realigning its spine business unit effective March 1, and the company named Jason Shallenberger as president of the bone growth therapies business.
Page 11 of 199